Revenue Agenda
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy
No Result
View All Result
Revenue Agenda
No Result
View All Result
Home Economy

EURGBP on a positive path this week, EURCHF is climbing 

by
February 22, 2024
in Economy
0
EURGBP on a positive path this week, EURCHF is climbing 
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

EURGBP on a positive path this week, EURCHF is climbing 

EURGBP continued this week’s previous bullish consolidation supported by the EMA200 moving average. EURCHF is climbing this week to a new high at the 0.95353 level.

EURGBP chart analysis

EURGBP continued this week’s previous bullish consolidation supported by the EMA200 moving average. On Tuesday, we saw a jump to a new weekly high at the 0.85783 level. After that, the pair went down to support in the EMA200 at the 0.85450 level and continued with bullish consolidation from there.

Today, we had more volatility on the chart, and the news about inflation in the Eurozone caused that. The data showed that inflation at 2.8% aligns with economists’ forecasts.

EURGBP once again tested the support of the EMA200 moving average, after which we successfully returned in the previous bullish channel. Potential higher targets are 0.85700 and 0.85750 levels.

The pair is under slight pressure at the 0.85650 level, and the inability to move above could trigger a bearish option. This would cause a pullback to the EMA200, and the potential lower targets are the 0.85500 and 0.85450 levels.

EURCHF chart analysis

EURCHF is climbing this week to a new high at the 0.95353 level. After that, we saw pullbacks to support at 0.95000 yesterday. We were close to testing the weekly open price. We are slowly approaching the EMA200 moving average, which is now in the zone around 0.94900 levels. Since the beginning of today’s EU session, the pair has been bullish, and we are very close to this week’s high.

If a stronger bullish impulse occurs, we could move above and form a new one. Potential higher targets are 0.95400 and 0.95500 levels. For a bearish option, it needs a negative consolidation and a drop to the support level at 0.95000. New pressure in that zone could lead to a breakout below and form a new low. Potential lower targets are 0.94900 and 0.94800 levels.

 

The post EURGBP on a positive path this week, EURCHF is climbing  appeared first on FinanceBrokerage.

Previous Post

Another GOP Biden ‘informant.’ Another indictment and link to Russia.

Next Post

Stellar forms this week’s low, BTC Cash at $266.00 Now

Next Post
Stellar forms this week’s low, BTC Cash at $266.00 Now

Stellar forms this week’s low, BTC Cash at $266.00 Now

  • Trending
  • Comments
  • Latest
Bitcoin Slips to $83.6K Amid Nvidia’s $5.5B Charge

Bitcoin Slips to $83.6K Amid Nvidia’s $5.5B Charge

October 7, 2025
Uranium Price Update: Q3 2025 in Review

Uranium Price Update: Q3 2025 in Review

October 16, 2025
Top 10 Potash Countries by Production (Updated 2024)

Top 10 Potash Countries by Production (Updated 2024)

August 21, 2024
Top 10 Phosphate Countries by Production (Updated 2024)

Top 10 Phosphate Countries by Production (Updated 2024)

August 1, 2024
Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

0
New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

New Hampshire Gov. Sununu signs $15.2B ‘miracle’ budget into law

0

Pennsylvania House clears tax credits for new teachers, nurses, police officers

0
Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

Evers signs bipartisan sales tax bill aimed at sparing Milwaukee from bankruptcy

0
Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

November 11, 2025
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

November 11, 2025
Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.

Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.

November 11, 2025
1911 Gold Intersects up to 24.83 g/t Gold over 2.60 m on San Antonio West at the True North Gold Project

1911 Gold Intersects up to 24.83 g/t Gold over 2.60 m on San Antonio West at the True North Gold Project

November 11, 2025
Enter Your Information Below To Receive Trading Ideas and Latest News

Error: Contact form not found.

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent News

Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

Mark Skousen: Gold, Silver in Major Bull Market, “Permanent Inflation” is Here

November 11, 2025
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

November 11, 2025
Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.

Questcorp Mining Receives Initial Investment from U.K. Based Institutional Investor Sorbie Bornholm LP.

November 11, 2025
1911 Gold Intersects up to 24.83 g/t Gold over 2.60 m on San Antonio West at the True North Gold Project

1911 Gold Intersects up to 24.83 g/t Gold over 2.60 m on San Antonio West at the True North Gold Project

November 11, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 revenueagenda.com | All Rights Reserved

No Result
View All Result
  • Investing
  • Latest News
  • Editor’s Pick
  • Economy

Copyright © 2025 revenueagenda.com | All Rights Reserved